Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 148 participants.

Also called NCT01584791

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 148 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01584791
Other papers using this trial's data
  • Comparison of antiplatelet efficacy and tolerability of clopidogrel napadisilate with clopidogrel bisulfate in coronary artery disease patients after percutaneous coronary intervention: a prospective, multicenter, randomized, open-label, phase IV, noninferiority trial Clinical therapeutics, 2013-01 DOI, PubMed 23328268

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
Not reported
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01584791. Randomized; no masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2012-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Korean Multicenter Randomized Controlled Trial (RCT) of Pidogul for Patients With Coronary Stenting
Intervention (Drug)
clopidogrel napadisilate + aspirin
Intervention (Drug)
clopidogrel bisulfate + aspirin
Lead sponsor
Seoul National University Hospital (class: other)
Collaborator
Hanmi Pharmaceutical co., ltd. (class: other)

Record details

Record id
cardio:ct-nct01584791
Content hash
73ac54aed1296bcb4e4661868864cef14423fa1c144baf692ddea43d5528d327